Specialty Pharmacy Program
Specialty medications include those used in the treatment of complex medical conditions, such as hepatitis, hemophilia, multiple sclerosis, rheumatoid arthritis and other conditions requiring self-administered specialty medications.
View the Specialty Drug List
Your prescription drug coverage may include a specialty pharmacy program through Triessent®*, which is part of our contracting pharmacy network.
Triessent Specialty Pharmacy Program
Through Triessent, members can have covered self-administered specialty medications delivered directly to them or their doctor’s office. When you purchase specialty medications through Triessent, you also receive at no additional charge the following services:
- Coordination of coverage between you, your doctor and Blue Cross and Blue Shield of Oklahoma
- Convenient delivery of medication to you or your physician’s office
- Educational materials about your particular condition and information about managing potential medication side effects
- Syringes, sharps containers and other supplies with every shipment for self-injectable medications
- 24/7/365 customer service phone access
To order through Triessent:
- Have your doctor call or fax your prescription to Triessent. Your doctor can call (888) 216-6710 or fax to (866) 203-6010.
- If your plan includes a specialty pharmacy program through Triessent and you have an existing prescription for a specialty medication, you can call (888) 216-6710 to transfer your prescription.
- A Triessent coordinator will contact you to arrange delivery of your medication.
If you have questions, please contact Triessent at (888) 216-6710 or call the customer service number listed on the back of your ID card. *Triessent is a specialty pharmacy program offered by Prime Therapeutics LLC, a pharmacy benefit management company. Blue Cross and Blue Shield of Illinois contracts with Prime Therapeutics to administer this specialty pharmacy program. Blue Cross and Blue Shield of Illinois as well as several other independent Blue Cross and Blue Shield Plans have an ownership interest in Prime Therapeutics.
|